IQVIA™ Real-World Insights Bibliography

Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5
Affiliations(s): 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France
Publication(s):  European Society of Cardiology (ESC) Congress, 2018, Munich, Germany
Document Type(s): Poster,
Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES
Author(s): M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. Díaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group
Affiliations(s): 1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway
Publication(s):  EULAR, Madrid, 2017
Document Type(s): Abstract,
Countries: Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland,
Click here for the abstract
C:
Y:
Rheumatology,
2017
  L:
A:
English
Epidemiological study,
  Add to report
 
 
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1.
Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden.
Publication(s):  Clinical Epidemiology
Document Type(s): Article,
Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK,
Click here for the abstract
C:
Y:
Oncology,
2016
  L:
A:
English
Literature Review,
  Add to report
 
 
Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe.
Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3
Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium
Publication(s):  19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Type(s): Abstract,
Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK,
C:
Y:
Cardiovascular disease,
2016
  L:
A:
English
  Add to report
 
 
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study.
Author(s): Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations(s): 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States
Publication(s):  Dig Liver Dis. 2016 Jun;48(6):601-7.
Document Type(s): Article,
Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK,
C:
Y:
Gastrointestinal disorders,
2016
  L:
A:
English
Burden of illness, Patient questionnaire, Survey research,
  Add to report
 
 
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study
Author(s): Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations(s): 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States.
Publication(s):  Dig Liver Dis. 2016 Jun;48(6):592-600
Document Type(s): Article,
Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK,
C:
Y:
Gastrointestinal disorders,
2016
  L:
A:
English
Burden of illness, Patient questionnaire,
  Add to report
 
 
ESTIMATION OF DIRECT MEDICAL COSTS ASSOCIATED WITH TREATMENT OF METASTATIC MELANOMA IN SWITZERLAND
Author(s): Christoffersen P1, Khan N1, Lucas J1, Christodoulopoulou A2, Del Ponte A2, Gutzwiller F2
Affiliations(s): 1IMS Health, Basel, Switzerland, 2Amgen Switzerland AG, Zug, Switzerland
Publication(s):  ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Type(s): Poster,
Countries: Switzerland,
C:
Y:
Oncology,
2015
  L:
A:
English
  Add to report
 
 
Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
Author(s): Samyshkin Y1, Schlunegger M2, Haefliger S3, Ledderhose S3, Radford M1
Affiliations(s): 1 IMS Health, HEOR, London, UK 2 Marketing Specialty Care 3 Takeda Pharma AG, Pfäffikon, Switzerland
Publication(s):  International Journal of COPD 8:79-87
Document Type(s): Article,
Countries: Switzerland,
C:
Y:
Respiratory disease,
2013
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Treatment cost of acute coronary syndrome with ticagrelor compared to clopidogrel in Switzerland.
Author(s): Gasche D1, Ulle T2, Meier B3, Greiner RA1
Affiliations(s): 1 IMS Health, Munich, Germany 2 AstraZeneca AG, Zug, Switzerland 3 Department of Cardiology, Bern University Hospital, Bern, Switzerland
Publication(s):  Gemeinsamen Jahrestagung der Schweizerischen Gesellschaften für Kardiologie und der Schweizerischen Gesellschaft für Herz- und Thorakale Gefässchirurgie - in press, 2013.
Document Type(s): Poster,
Countries: Switzerland,
C:
Y:
Cardiovascular disease,
2013
  L:
A:
English
Cost analysis,
  Add to report
 
 
Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden.
Author(s): Valentine WJ1, Aagren M2, Haglund M3-4, Ericsson A3, Gschwend MH5
Affiliations(s): 1Ossian Health Economics and Communication, Basel, Switzerland, 2Novo Nordisk Inc., Princeton, NJ, USA, 3Novo Nordisk Scandinavia AB, Malmo, Sweden, 4NeuroSearch A/S, Ballerup, Denmark and 5IMS Health, Basel, Switzerland
Publication(s):  Scandinavian journal of public health
Document Type(s): Manuscript in preparation,
Countries: Switzerland,
Click here for the abstract
C:
Y:
Diabetes,
2011
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
 1 of 2 Next Page Last Page